Literature DB >> 27819803

Differences in work environment for staff as an explanation for variation in central line bundle compliance in intensive care units.

Yuna S H Lee1, Patricia W Stone, Monika Pogorzelska-Maziarz, Ingrid M Nembhard.   

Abstract

BACKGROUND: Central line-associated bloodstream infections (CLABSIs) are a common and costly quality problem, and their prevention is a national priority. A decade ago, researchers identified an evidence-based bundle of practices that reduce CLABSIs. Compliance with this bundle remains low in many hospitals.
PURPOSE: The aim of this study was to assess whether differences in core aspects of work environments-workload, quality of relationships, and prioritization of quality-are associated with variation in maximal CLABSI bundle compliance, that is, compliance 95%-100% of the time in intensive care units (ICUs). METHODOLOGY/APPROACH: A cross-sectional study of hospital medical-surgical ICUs in the United States was done. Data on work environment and bundle compliance were obtained from the Prevention of Nosocomial Infections and Cost-Effectiveness Refined Survey completed in 2011 by infection prevention directors, and data on ICU and hospital characteristics were obtained from the National Healthcare Safety Network. Factor and multilevel regression analyses were conducted.
FINDINGS: Reasonable workload and prioritization of quality were positively associated with maximal CLABSI bundle compliance. High-quality relationships, although a significant predictor when evaluated apart from workload and prioritization of quality, had no significant effect after accounting for these two factors. PRACTICE IMPLICATIONS: Aspects of the staff work environment are associated with maximal CLABSI bundle compliance in ICUs. Our results suggest that hospitals can foster improvement in ensuring maximal CLABSI bundle compliance-a crucial precursor to reducing CLABSI infection rates-by establishing reasonable workloads and prioritizing quality.

Entities:  

Mesh:

Year:  2018        PMID: 27819803      PMCID: PMC5418105          DOI: 10.1097/HMR.0000000000000134

Source DB:  PubMed          Journal:  Health Care Manage Rev        ISSN: 0361-6274


  33 in total

1.  The 100,000 lives campaign: setting a goal and a deadline for improving health care quality.

Authors:  Donald M Berwick; David R Calkins; C Joseph McCannon; Andrew D Hackbarth
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

2.  Use of central venous catheter-related bloodstream infection prevention practices by US hospitals.

Authors:  Sarah L Krein; Timothy P Hofer; Christine P Kowalski; Russell N Olmsted; Carol A Kauffman; Jane H Forman; Jane Banaszak-Holl; Sanjay Saint
Journal:  Mayo Clin Proc       Date:  2007-06       Impact factor: 7.616

3.  Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project.

Authors:  Peter Pronovost
Journal:  Am J Infect Control       Date:  2008-12       Impact factor: 2.918

4.  Creating a quality-improvement dialogue: utilizing knowledge from frontline staff, managers, and experts to foster health care quality improvement.

Authors:  Louise E Parker; JoAnn E Kirchner; Laura M Bonner; Jacqueline J Fickel; Mona J Ritchie; Carol E Simons; Elizabeth M Yano
Journal:  Qual Health Res       Date:  2008-12-17

5.  Explaining Michigan: developing an ex post theory of a quality improvement program.

Authors:  Mary Dixon-Woods; Charles L Bosk; Emma Louise Aveling; Christine A Goeschel; Peter J Pronovost
Journal:  Milbank Q       Date:  2011-06       Impact factor: 4.911

6.  Impact of self-reported guideline compliance: Bloodstream infection prevention in a national collaborative.

Authors:  Yea-Jen Hsu; Kristina Weeks; Ting Yang; Melinda D Sawyer; Jill A Marsteller
Journal:  Am J Infect Control       Date:  2014-10       Impact factor: 2.918

7.  Preventing hospital-acquired urinary tract infection in the United States: a national study.

Authors:  Sanjay Saint; Christine P Kowalski; Samuel R Kaufman; Timothy P Hofer; Carol A Kauffman; Russell N Olmsted; Jane Forman; Jane Banaszak-Holl; Laura Damschroder; Sarah L Krein
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

8.  Nurse working conditions and patient safety outcomes.

Authors:  Patricia W Stone; Cathy Mooney-Kane; Elaine L Larson; Teresa Horan; Laurent G Glance; Jack Zwanziger; Andrew W Dick
Journal:  Med Care       Date:  2007-06       Impact factor: 2.983

9.  Central line bundle implementation in US intensive care units and impact on bloodstream infections.

Authors:  E Yoko Furuya; Andrew Dick; Eli N Perencevich; Monika Pogorzelska; Donald Goldmann; Patricia W Stone
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

10.  Nursing workload as a risk factor for healthcare associated infections in ICU: a prospective study.

Authors:  Renata M Daud-Gallotti; Silvia F Costa; Thais Guimarães; Katia Grillo Padilha; Evelize Naomi Inoue; Tiago Nery Vasconcelos; Fernanda da Silva Cunha Rodrigues; Edizângela Vasconcelos Barbosa; Walquíria Barcelos Figueiredo; Anna S Levin
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more
  2 in total

1.  Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies.

Authors:  Stijn Blot; Etienne Ruppé; Stephan Harbarth; Karim Asehnoune; Garyphalia Poulakou; Charles-Edouard Luyt; Jordi Rello; Michael Klompas; Pieter Depuydt; Christian Eckmann; Ignacio Martin-Loeches; Pedro Povoa; Lila Bouadma; Jean-Francois Timsit; Jean-Ralph Zahar
Journal:  Intensive Crit Care Nurs       Date:  2022-03-03       Impact factor: 4.235

2.  Assessment of Knowledge on the Prevention of Central-Line-Associated Bloodstream Infections among Intensive Care Nurses in Poland-A Prospective Multicentre Study.

Authors:  Danuta Dyk; Agata Matusiak; Edyta Cudak; Aleksandra Gutysz-Wojnicka; Wioletta Mędrzycka-Dąbrowska
Journal:  Int J Environ Res Public Health       Date:  2021-12-01       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.